Pathogen Reduction for Platelets—A Review of Recent Implementation Strategies

The development of pathogen reduction technologies (PRT) for labile blood components is a long-pursued goal in transfusion medicine. While PRT for red blood cells and whole blood are still in an early phase of development, different PRT platforms for plasma and platelets are commercially available a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebulla, Paolo, Prati, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879285/
https://www.ncbi.nlm.nih.gov/pubmed/35215085
http://dx.doi.org/10.3390/pathogens11020142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879285/
https://www.ncbi.nlm.nih.gov/pubmed/35215085
http://dx.doi.org/10.3390/pathogens11020142

Ejemplares similares